跳至主要内容
临床试验/NCT05677984
NCT05677984已完成不适用

Comparison the Prescription of Duration of Awaken Prone Positioning Ventilation Duration in COVID-19 Patients: a Randomised Controlled Study

Southeast University, China1 个研究点 分布在 1 个国家目标入组 409 人开始时间: 2023年1月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
409
试验地点
1
主要终点
28-day intubation rate

研究概览

简要总结

Awaken prone positioning (APP) ventilation has been widely accepted as a standard regimen in the management of COVID-19 patients. Physiological studies have proved ventilation/perfusion improvement during APP in COVID-19, which was associated improved oxygenation. However, the optimal duration for APP was not yet demonstrated. In this study, we aimed at the prolonged APP to see whether this could improve patients outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged > 18-yr to 85-yr
  • Severe COVID-19 pneumonia (with typical radiographic alternations) and non-intubated patients.
  • SpO2 <= 93% with ambient air at rest.
  • PaO2/FiO2 <= 300 mmHg

排除标准

  • Definite intolerance to APP (e.g. pregnancy, extremity deformity, recent fracture, open thoracic or abdominal surgery, pace-maker implant in recent 48-hr, spine stability, pelvis or facial fractures, predicted difficult airway)
  • morbidity obesity, BMI > 40
  • consciousness disorder (GCS < 13), delirium dementia
  • hemodynamic instability (with norepinephrine >20 ug/min )
  • NYHA Grade III or IV
  • Severe hemoptysis
  • long term home oxygenation of CPAP
  • Refuse invasive mechanical ventilation (DNI DNR)

结局指标

主要结局

28-day intubation rate

时间窗: follow-up till 28-day

whether the patients' were intubated

次要结局

  • mortality (ICU hospital) length of ICU (hospital) stay(follow-up during the ICU/hospital stay, up to 28 days)
  • APP duration/days(follow-up till APP ended, daily duration of APP also recoreded, up to 7 days)
  • Application of HFNC NIV vasopressor CRRT ECMO sedation, or complication(follow-up till 28-day)

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ling Liu

Professor

Southeast University, China

研究点 (1)

Loading locations...

相似试验